Correlation Between Revolution Medicines and Stoke Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Revolution Medicines and Stoke Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revolution Medicines and Stoke Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revolution Medicines and Stoke Therapeutics, you can compare the effects of market volatilities on Revolution Medicines and Stoke Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revolution Medicines with a short position of Stoke Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revolution Medicines and Stoke Therapeutics.

Diversification Opportunities for Revolution Medicines and Stoke Therapeutics

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Revolution and Stoke is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Revolution Medicines and Stoke Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Stoke Therapeutics and Revolution Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revolution Medicines are associated (or correlated) with Stoke Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Stoke Therapeutics has no effect on the direction of Revolution Medicines i.e., Revolution Medicines and Stoke Therapeutics go up and down completely randomly.

Pair Corralation between Revolution Medicines and Stoke Therapeutics

Given the investment horizon of 90 days Revolution Medicines is expected to generate 64.15 times less return on investment than Stoke Therapeutics. But when comparing it to its historical volatility, Revolution Medicines is 2.17 times less risky than Stoke Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Stoke Therapeutics is currently generating about 0.3 of returns per unit of risk over similar time horizon. If you would invest  918.00  in Stoke Therapeutics on May 26, 2025 and sell it today you would earn a total of  1,038  from holding Stoke Therapeutics or generate 113.07% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Revolution Medicines  vs.  Stoke Therapeutics

 Performance 
       Timeline  
Revolution Medicines 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Revolution Medicines has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Revolution Medicines is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Stoke Therapeutics 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Stoke Therapeutics are ranked lower than 23 (%) of all global equities and portfolios over the last 90 days. Despite quite unsteady basic indicators, Stoke Therapeutics disclosed solid returns over the last few months and may actually be approaching a breakup point.

Revolution Medicines and Stoke Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Revolution Medicines and Stoke Therapeutics

The main advantage of trading using opposite Revolution Medicines and Stoke Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revolution Medicines position performs unexpectedly, Stoke Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stoke Therapeutics will offset losses from the drop in Stoke Therapeutics' long position.
The idea behind Revolution Medicines and Stoke Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Money Managers
Screen money managers from public funds and ETFs managed around the world
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios